Stocks ACT Financial statements
Financial statementsEnact Holdings, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Enact Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 979 | 1,106 | 1,118 | 1,095 | 1,154 | 1,202 | 1,236 |
| Selling, general and administrative | 215 | 231 | 227 | 212 | 213 | 208 | |
| Interest expense | 0 | 18.2 | 51 | 51.7 | 51.9 | 51.2 | 49.9 |
| Pre-tax income | 718 | 472 | 695 | 898 | 852 | 878 | 859 |
| Income tax | 156 | 102 | 149 | 194 | 186 | 190 | 185 |
| Net income | 678 | 370 | 547 | 704 | 666 | 688 | 674 |
| EPS, basic | 4.16 | 2.27 | 3.36 | 4.32 | 4.14 | 4.40 | 4.54 |
| EPS, diluted | 4.16 | 2.27 | 3.36 | 4.31 | 4.11 | 4.37 | 4.52 |
| Shares, basic (weighted) | 163 | 163 | 163 | 163 | 161 | 156 | 148 |
| Shares, diluted (weighted) | 163 | 163 | 163 | 163 | 162 | 158 | 149 |
| Dividend per share | 1.54 | 1.33 | 0.72 | 0.82 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 585 | 453 | 426 | 514 | 616 | 599 | 582 |
| Short-term investments | 0 | 0 | 3.05 | 20.2 | 3.37 | 0 | |
| Lease right-of-use assets | 18.1 | 15.5 | 13.6 | 11.3 | 8.8 | 6.6 | |
| Total assets | 5,653 | 5,866 | 5,709 | 6,190 | 6,522 | 6,893 | |
| Total liabilities | 1,771 | 1,760 | 1,608 | 1,558 | 1,525 | 1,538 | |
| Total debt | 738 | 740 | 743 | 745 | 743 | 744 | |
| Paid-in capital | 2,369 | 2,372 | 2,382 | 2,311 | 2,077 | 1,706 | |
| Retained earnings | 1,303 | 1,648 | 2,100 | 2,550 | 3,125 | 3,677 | |
| Other comprehensive income | 208 | 83.6 | -383 | -230 | -207 | -30.1 | |
| Shareholders' equity | 3,827 | 3,882 | 4,106 | 4,101 | 4,632 | 4,996 | 5,355 |
| Total equity | 3,827 | 3,882 | 4,106 | 4,101 | 4,632 | 4,996 | 5,355 |
| Total liabilities and equity | 5,653 | 5,866 | 5,709 | 6,190 | 6,522 | 6,893 | |
| Shares outstanding | 163 | 163 | 163 | 159 | 152 | 142 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 678 | 370 | 547 | 704 | 666 | 688 | 674 |
| Stock-based compensation | 0 | 0 | 1.5 | 9.88 | 15.3 | 18.8 | 19 |
| Deferred income tax | 56.7 | 11.1 | -1.42 | -2.3 | -1.83 | 4.46 | 7.77 |
| Cash from operations | 500 | 704 | 572 | 561 | 632 | 686 | 725 |
| Purchases of investments | -951 | -1,942 | -1,583 | -1,216 | -1,018 | -1,606 | -1,896 |
| Sales and maturities of investments | 359 | 527 | 713 | 471 | 396 | 735 | 912 |
| Cash from investing | 176 | -1,137 | -399 | -220 | -229 | -321 | -226 |
| Debt issued | 0 | 738 | 0 | 0 | 0 | 750 | 0 |
| Stock issued | 0 | 0 | 0 | 0 | 0 | ||
| Share buybacks | 0 | 0 | -1.53 | -87.8 | -244 | -382 | |
| Dividends paid | -250 | -437 | -200 | -251 | -213 | -112 | -121 |
| Cash from financing | -250 | 300 | -200 | -252 | -301 | -382 | -515 |
| Exchange rate effect | 0 | 0 | -0.01 | ||||
| Net change in cash | 426 | -132 | -27 | 87.9 | 102 | -16.3 | -16.9 |
| Interest paid | 0 | 0 | 47.9 | 49.1 | 49.2 | 62.9 | 47.4 |
| Income taxes paid | 166 | 57 | 146 | 186 | 182 | 189 | 191 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Pre-tax margin | 69.1% | Pre-tax income / revenue. |
| Net margin | 54.5% | Net income / revenue. |
| Operating cash flow margin | 57.5% | Cash from operations / revenue. |
| Effective tax rate | 21.1% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 12.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 9.8% | Net income / average total assets. |
| Stock-based pay / revenue | 1.6% | Stock-based compensation (from the cash flow statement) / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 2.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 4.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 2.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -2.0% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -1.4% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 12.7% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 3.4% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 1.6% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 14.8% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 5.6% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 8.9% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 0.6% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 14.0% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | -19.1% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 7.2% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 9.3% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 6.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 5.7% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 6.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 4.0% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -5.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -2.9% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -1.7% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Debt / equity | 0.14x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 10.7% | Total debt / total assets. |
| Liabilities / assets | 22.4% | Total liabilities / total assets. |
| Net debt | $247.7M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Tangible book value | $5.40B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.18x | Revenue / average total assets. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $4.87 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $8.93 | Revenue / diluted weighted shares. |
| Operating cash flow per share | $5.14 | Cash from operations / diluted weighted shares. |
| Book value per share | $39.06 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $39.06 | Tangible book value / shares outstanding. |
| Cash per share | $3.60 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 18.2% | Dividends paid / net income, when net income is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $6.46B | Share price x shares outstanding. |
| Enterprise value | $6.71B | Market cap + total debt - cash - short-term investments. |
| P/E | 9.45x | Market cap / net income. Only when net income is positive. |
| P/S | 5.15x | Market cap / revenue. |
| P/B | 1.20x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.20x | Market cap / tangible book value, when positive. |
| P/OCF | 8.96x | Market cap / cash from operations, when positive. |
| EV/Sales | 5.35x | Enterprise value / revenue. |
| Earnings yield | 10.6% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 1.9% | Dividends paid over the period / market cap. |
| Shareholder yield | 8.4% | (Dividends paid + share buybacks) / market cap. |
| PEG | 5.91x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Enact Holdings, Inc.'s revenue in fiscal 2025?
Enact Holdings, Inc. reported revenue of $1.24B for fiscal 2025, 2.8% higher than the year before.
Was Enact Holdings, Inc. profitable in fiscal 2025?
Yes. Net income was $674.2M, a net margin of 54.6%.